Revolution Medicines (RVMD) shares outstanding: 216.3M
Revolution Medicines had 216.3M shares outstanding on Oct 30, 2026, up 11.9% from 193.3M a year earlier.
From Revolution Medicines's filings with the SEC · RVMD stock page
Revolution Medicines shares outstanding by year
#627 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 30, 2026 | 216.3M | +12% |
| Oct 31, 2025 | 193.3M | +15% |
| Nov 4, 2024 | 168.2M | +54% |
| Nov 1, 2023 | 109.6M | +23% |
| Nov 2, 2022 | 88.8M | – |
Shares outstanding of similar companies
Companies in the same industry as Revolution Medicines, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Exelixis | 244.0M | Oct 19, 2026 |
| ADMA Biologics | 221.9M | Oct 30, 2026 |
| Relay Therapeutics | 221.0M | Oct 30, 2026 |
| Qiagen | 216.9M | Dec 31, 2025 |
| Revolution Medicines | 216.3M | Oct 30, 2026 |
| Immunovant | 206.9M | Nov 3, 2026 |
| Prime Medicine | 181.9M | Oct 31, 2026 |
Questions and answers
What is Revolution Medicines's shares outstanding?
Revolution Medicines had 216.3M shares outstanding on Oct 30, 2026, up 11.9% from 193.3M a year earlier.
Numbers as reported in Revolution Medicines's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology